Usana Health Sciences (USNA) Operating Margin (2010 - 2026)

Usana Health Sciences (USNA) has reported Operating Margin for 17 consecutive years, with 8.96% the latest figure, recorded in Q3 2026.

• On a quarterly basis, Operating Margin fell 1604.0% year-over-year to 8.96% in Q3 2026; TTM through Jul 2026 was 0.12%, a 637.0% decrease from a year earlier, with the FY2026 full-year figure at 4.05%, down 372.0% from the prior year.
• Operating Margin was 8.96% for Q3 2026 at Usana Health Sciences, down from 5.54% in the prior quarter.
• Over five years, Operating Margin peaked at 12.76% in Q1 2022 and troughed at 8.96% in Q3 2026.
• A 5-year average of 7.31% and a median of 8.38% in 2024 frame the typical range for Operating Margin.
• Across the five-year window, Operating Margin soared 106 bps in 2023 and tumbled 1604 bps in 2026, its largest moves.
• Over 5 years, Operating Margin stood at 9.89% in 2022, then increased by 11 bps to 10.95% in 2023, then sank by 65 bps to 3.84% in 2024, then slumped by 85 bps to 0.57% in 2025, then plunged by 1663 bps to 8.96% in 2026.
• The last three Operating Margin figures came in at 8.96% (Q3 2026), 5.54% (Q2 2026), and 1.69% (Q1 2026), per Business Quant data.